Avidity Biosciences (RNA) News Today $28.80 -0.37 (-1.27%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$28.80 0.00 (0.00%) As of 07/7/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Mirae Asset Global Investments Co. Ltd. Boosts Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)July 6 at 3:29 AM | marketbeat.comAvidity Biosciences, Inc. (RNA) - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comCantor Fitzgerald Reiterates "Overweight" Rating for Avidity Biosciences (NASDAQ:RNA)June 28, 2025 | americanbankingnews.com7RNA : Expert Outlook: Avidity Biosciences Through The Eyes...June 27, 2025 | benzinga.comAvidity Biosciences (NASDAQ:RNA) Receives "Overweight" Rating from Cantor FitzgeraldJune 27, 2025 | marketbeat.comAvidity Biosciences’ SWOT analysis: innovative RNA therapies stock faces pivotal yearJune 26, 2025 | investing.comAvidity Biosciences, Inc. (NASDAQ:RNA) Receives Average Rating of "Buy" from AnalystsJune 26, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Earns Outperform Rating from Analysts at Sanford C. BernsteinJune 24, 2025 | marketbeat.comAvidity, Dyne get Bernstein ratings as oligonucleotide muscle trials advanceJune 24, 2025 | investing.comSG Americas Securities LLC Takes $516,000 Position in Avidity Biosciences, Inc. (NASDAQ:RNA)June 23, 2025 | marketbeat.comAvidity Biosciences’ SWOT analysis: innovative RNA firm eyes 3-drug launch by 2027June 20, 2025 | investing.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells $27,548.64 in StockJune 19, 2025 | insidertrades.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Kathleen P. Gallagher Sells 911 SharesJune 18, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Trading Up 4.1% - Here's WhyJune 17, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Coverage Initiated at Wolfe ResearchJune 17, 2025 | marketbeat.comAvidity Biosciences’ SWOT analysis: innovative RNA tech targets rare disease stock potentialJune 16, 2025 | investing.comAvidity Biosciences (NASDAQ:RNA) Shares Down 3.5% - Here's What HappenedJune 16, 2025 | marketbeat.comAssenagon Asset Management S.A. Increases Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)June 15, 2025 | marketbeat.comRhumbline Advisers Increases Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)June 14, 2025 | marketbeat.comGAMMA Investing LLC Has $1.96 Million Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA)June 14, 2025 | marketbeat.comW. Michael Flanagan Sells 20,000 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) StockJune 12, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic View of RNA FY2026 EarningsJune 12, 2025 | marketbeat.comRaymond James Initiates Coverage of Avidity Biosciences (RNA) with Strong Buy RecommendationJune 12, 2025 | msn.comAvidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond JamesJune 11, 2025 | msn.comAvidity Biosciences to Present Topline Data from Phase 1/2 FORTITUDE™ Trial of Del-brax in People Living with Facioscapulohumeral Muscular Dystrophy at 32nd Annual FSHD Society International Research CongressJune 11, 2025 | prnewswire.comCantor Fitzgerald Weighs in on RNA FY2026 EarningsJune 11, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Coverage Initiated by Analysts at Raymond JamesJune 11, 2025 | marketbeat.com1RNA : The Analyst Verdict: Avidity Biosciences In The Eyes Of 12 ExpertsJune 10, 2025 | benzinga.comCitigroup Increases Avidity Biosciences (NASDAQ:RNA) Price Target to $75.00June 10, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, Barclays Analyst SaysJune 10, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysJune 10, 2025 | marketbeat.comAvidity Biosciences stock falls following positive trial dataJune 10, 2025 | investing.comAvidity Biosciences Touts Encouraging Functional Gains And Biomarker Reductions In Rare Muscular Weakness Disease TrialJune 9, 2025 | finance.yahoo.comAvidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, Bank of America Analyst SaysJune 9, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Shares Gap Up Following Analyst UpgradeJune 9, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Price Target Raised to $75.00June 9, 2025 | marketbeat.comAvidity Biosciences Announces Positive Topline Phase 1/2 FORTITUDE™ Data Demonstrating Consistent Improvement Across Multiple Functional Measures Compared to Placebo in Del-Brax Treated FSHD ParticipantsJune 9, 2025 | prnewswire.comAvidity Biosciences Announces the Accelerated Approval Regulatory Pathway in the U.S. is Open for Del-Brax and Initiates the Global, Confirmatory Phase 3 FORWARD™ Study in FSHDJune 9, 2025 | prnewswire.comCalifornia State Teachers Retirement System Increases Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA)June 7, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by Hennion & Walsh Asset Management Inc.June 6, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells $190,820.00 in StockJune 5, 2025 | marketbeat.comTwo Sigma Advisers LP Trims Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA)June 5, 2025 | marketbeat.comAvidity Biosciences Target of Unusually Large Options Trading (NASDAQ:RNA)June 4, 2025 | marketbeat.comAmeriprise Financial Inc. Has $798,000 Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)June 3, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)June 2, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)June 1, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Receives Average Rating of "Buy" from BrokeragesJune 1, 2025 | marketbeat.comNuveen Asset Management LLC Sells 706,062 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)May 29, 2025 | marketbeat.comBank of America Corp DE Sells 1,164,431 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)May 29, 2025 | marketbeat.comVoloridge Investment Management LLC Purchases 134,489 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)May 28, 2025 | marketbeat.com Get Avidity Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter. Email Address RNA Media Mentions By Week RNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNA News Sentiment▼0.920.57▲Average Medical News Sentiment RNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNA Articles This Week▼28▲RNA Articles Average Week Get Avidity Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genmab A/S News Today Dr. Reddy's Laboratories News Today QIAGEN News Today Viatris News Today Ascendis Pharma A/S News Today Moderna News Today BridgeBio Pharma News Today Blueprint Medicines News Today Verona Pharma PLC American Depositary Share News Today Roivant Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNA) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
